ReviewFrontiers in pharmacology2023

Meta-analysis and trial sequential analysis of ezetimibe for coronary atherosclerotic plaque compositions.

Bofeng Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.